Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy
The concept of “liquid biopsy” has gained high interest in oncology and is being studied more as it is gradually getting incorporated in patient care for multiple cancer types. Liquid biopsy describes the analysis of circulating tumor cells (CTCs) or smaller pieces of cancer cells such as
Authors
- Jérémie Calais (ORCID: https://orcid.org/0000-0002-8839-4379)
- Matthew B. Rettig (ORCID: https://orcid.org/0000-0002-7394-3056)
- Alexandra Drakaki (ORCID: https://orcid.org/0000-0001-8865-3548)
- Yazhen Zhu (ORCID: https://orcid.org/0000-0002-2130-8085)
- Adrien Holzgreve (ORCID: https://orcid.org/0000-0002-9566-8438)
- Christine E. Mona
- Hsian‐Rong Tseng (ORCID: https://orcid.org/0000-0003-0942-5905)
- John K. Lee (ORCID: https://orcid.org/0000-0002-6570-2180)
- Isla P. Garraway (ORCID: https://orcid.org/0000-0002-1129-4636)
- Xinmin Li (ORCID: https://orcid.org/0000-0001-9137-3598)
- Koichiro Kimura
- Ali Salavati (ORCID: https://orcid.org/0000-0002-1909-6175)
Institutions
- California NanoSystems Institute (US)
- University of California, Los Angeles (US)
- LMU Klinikum (DE)
- Institut thématique Génétique, génomique et bioinformatique (FR)
- Molecular Theranostics (United States) (US)
- VA Greater Los Angeles Healthcare System (US)
- UCLA Jonsson Comprehensive Cancer Center
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2025-11-13
- DOI
- https://doi.org/10.2967/jnumed.125.270651
- Citations
- 1
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.05